A5091305831- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Pelvic floor disorders treatments
- Urinary Bladder and Prostate Research
- Bladder and Urothelial Cancer Treatments
- Urological Disorders and Treatments
- Urinary and Genital Oncology Studies
- Urologic and reproductive health conditions
- Renal cell carcinoma treatment
- Renal and related cancers
- Ureteral procedures and complications
- Urinary Tract Infections Management
- Anorectal Disease Treatments and Outcomes
- Surgical Simulation and Training
- Pediatric Urology and Nephrology Studies
- Multiple and Secondary Primary Cancers
- Cancer, Lipids, and Metabolism
- Cancer Research and Treatments
- Kidney Stones and Urolithiasis Treatments
- Renal and Vascular Pathologies
- Radiopharmaceutical Chemistry and Applications
- Renal Transplantation Outcomes and Treatments
- Colorectal Cancer Screening and Detection
- Organ Donation and Transplantation
- Hormonal and reproductive studies
Hospital Clínico San Carlos
2016-2025
Universidad Complutense de Madrid
2006-2025
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
2015-2023
Hospital Clínico Universitario de Valencia
2010-2012
Urology Team
2011
Hospital Universitario de Fuenlabrada
2009
To evaluate the feasibility and long-term outcomes of our initial series robot-assisted laparoscopic sacrocolpopexy.We conducted a prospective analysis robotic sacrocolpopexy.patients with grades III IV cystocele or other symptomatic pelvic organ prolapse. We performed transperitoneal four-trocar technique Da Vinci system using two polypropylene meshes for fixation to sacral promontory. The primary outcome was recurrence; secondary included operating room time, blood loss, conversion open...
We estimate the annual incidence of bladder cancer in Spain and describe clinical profile patients with enrolled a population based study.Using structure Spanish National Health System as basis, 2011 AEU (Spanish Association Urology) conducted this study representative sample from 26 public hospitals reference 10,146,534 inhabitants, comprising 21.5% population.A total 4,285 episodes were diagnosed, which 2,476 (57.8%) new cases 1,809 (42.2%) recurrence, representing an estimated 11,539...
Bladder cancer occurs in the epithelial lining of urinary bladder and is amongst most common types humans, killing thousands people a year. This paper based on hypothesis that use clinical histopathological data together with information about concentration various molecular markers patients useful for prediction outcomes design treatments nonmuscle invasive carcinoma (NMIBC). A population 45 new diagnosis NMIBC was selected. Patients benign prostatic hyperplasia (BPH), muscle (MIBC), situ...
Despite good long-term outcomes of kidney transplants from controlled donation after circulatory death (DCD) donors, there are few uncontrolled DCD (uDCD) programs. This longitudinal study compares for all uDCD (N = 774) and brain (DBD) 613) performed 1996 to 2015 at our center. DBD were divided into those standard-criteria (SCD) 366) expanded-criteria 247) brain-dead donors (ECD). One-, 5-, 10-year graft survival rates 91.7%, 85.7%, 80.6% SCD; 86.0%, 75.8%, 61.4% ECD; 85.1%, 78.1%, 72.2%...
Pretreatment assessment of patients diagnosed with localized prostate cancer (PCa) is essential for therapeutic decision-making. Currently available staging systems based on prostate-specific antigen (PSA), Gleason score, and clinical stage allow determining the prognostic characteristics these patients. Several studies have evaluated preoperative use density (PSAD) as a factor further risk stratification. To date, role PSAD in this setting still an object debate.
Abstract Functional Tregs play a key role in tumor development and progression, representing major barrier to anticancer immunity. The mechanisms by which are generated cancer the influence of microenvironment on these processes remain incompletely understood. Herein, using NMR, chemoenzymatic structural assays plethora vitro vivo functional analyses, we demonstrate that tumoral carbohydrate A10 (Ca10), cell-surface derived from Ehrlich’s (ET) cells, is heparan sulfate-related proteoglycan...
Neuroprotection of erythropoietin (EPO) following long-term administration is hampered by the associated undesirable effects on hematopoiesis and body weight. For this reason, we tested carbamylated-EPO (CEPO), which has no effect erythropoiesis, compared it with EPO in AβPP/PS1 mouse model familial Alzheimer’s disease. Groups 5-month old wild type (WT) transgenic mice received chronic treatment consisting CEPO (2,500 or 5,000 UI/kg) U I/kg) 3 days/week for 4 weeks. Memory at end was...
<i>Background:</i> The number of robotic-assisted procedures offered in Spain is rapidly increasing despite a lack consensus criteria for training and credentialling. <i>Objective:</i> This national multicentre study was designed to analyze the different areas robotic urological surgery learning curve. <i>Material Methods:</i> A questionnaire sent all 13 urology units with an active robotics programme requesting information on problems encountered....
Over the last three decades, European Randomized Study of Screening for Prostate Cancer (ERSPC) and US-based Prostate, Lung, Colorectal Ovarian (PLCO) have steered conversation around early detection prostate cancer. These two randomized trials assessed effect screening on cancer disease-specific mortality. Elevated PSA levels were followed by a systematic sextant biopsy. Standard repeat testing intervals applied. After controversies from 2009 to 2016 due contradicting results trials,...